Value Stock Pick Newsletter
Our New Pick Is CBIS Good Morning Traders! As I discussed yesterday in our full research report, CBIS is a medical marijuana company at the forefront of the single most important societal change occurring right now in the United States: The run towards legalization nationwide of marijuana for medical purposes.
New York is the latest and greatest of the new wave to join the revolution. And it is a ‘new wave’ in the making. Reports out yesterday suggest Oregon may be next to get in line as an initiative has now put it on the ballot for November. If you’ve ever been to Oregon then you know the result is a given.
There are still some 30 states left to join the fun, and the wheels are turning at the federal level as well.
The table is a huge one and every leading brand in the game is going to get seriously paid on the back and front end. The tea leaves are starting to suggest now is the time to start to make a move in some of the high flyers from January and February that have pulled back.
CBIS is at the top of that list in terms of value and discount. And the technicals are starting to tell a tale of promise. This stock has pulled back right into the slingshot just as the weed story starts to boot up the 2.0 version. Get ready this morning to do your part and take advantage of this massive trading opportunity.
Symbol: CBIS Company: Cannabis Science, Inc.
Quote: email@example.com to your contact list (address book) or safe sender list. Add us now to ensure you get our sent directly to your email inbox and not your junk-spam-box. Remember, timing is everything in the markets and that`s why its important to add us now.
Disclaimer This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment a dvice. The content in this report or email is not provided to any individual with a view toward their individual circumstances.
ValueStockPick.com is a web property owned by Brilliant Innovators has been compensated up to six thousand USD for the release of this email. Brilliant Innovators affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the market. Brilliant Innovators owns no shares of any companies mentioned in this email. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision.
While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of your investment.
FOR COMPLETE COMPENSATION DISCLOSURE AND RISKS INVOLVED PLEASE VIEW OUR FULL DISCLAIMER AT:http://www.valuestockpick.com/disclaimer/
1162 Stanford Rd. Hall Green, B28 8AF, Birmingham, United Kingdom